CS logo
small CS logo
GASTROMED Sp. z o.o.

Lublin, Poland
Medical center in Lublin
Onyksowa 10, 20-582 Lublin

About GASTROMED Sp. z o.o.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Janssen Research & Development, LLC
4
Takeda
4
Celgene
2
Hoffmann-La Roche
2
Pfizer
2
Total Rows: 6

Clinical Trials at GASTROMED Sp. z o.o.


During the past decade, GASTROMED Sp. z o.o. conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44221144221100220000000022331122Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
2014-11-04
2020-03-19
Completed
358
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
2015-06-29
2019-01-18
Completed
771
Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease
2015-10-09
2019-11-28
Completed
69
Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
2015-12-08
2018-01-05
Terminated
701
Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)
2016-01-04
2019-08-06
Completed
644
Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
2015-12-18
2018-08-21
Completed
383
A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
2016-04-15
2023-05-06
Active, not recruiting
746

Rows per page:

1–18 of 18

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "GASTROMED Sp. z o.o." #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Takeda" with 4 trials sponsored, "Celgene" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 6 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 4Eli Lilly and Company: 4Janssen Research &Development, LLC: 4Janssen Research &Development, LLC: 4Takeda: 4Takeda: 4Celgene: 2Celgene: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2Pfizer: 2Pfizer: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at GASTROMED Sp. z o.o.


According to Clinical.Site data, the most researched conditions in "GASTROMED Sp. z o.o." are "Crohn's Disease" (8 trials), "Ulcerative Colitis" (6 trials), "Colitis, Ulcerative" (4 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "GASTROMED Sp. z o.o." in a lesser frequency.

Clinical Trials Intervention Types at GASTROMED Sp. z o.o.


Most popular intervention types in "GASTROMED Sp. z o.o." are "Drug" (18 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Guselkumab" (4 trials), "Mirikizumab" (3 trials), "Adalimumab" (2 trials) and "Etrolizumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at GASTROMED Sp. z o.o.


The vast majority of trials in "GASTROMED Sp. z o.o." are 18 trials for "All" genders.

Clinical Trials Status at GASTROMED Sp. z o.o.


Currently, there are NaN active trials in "GASTROMED Sp. z o.o.". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in GASTROMED Sp. z o.o., undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in GASTROMED Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 13Phase 3: 13Phase 2: 7Phase 2: 7

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 7Active, not recruiting: 7Completed: 6Completed: 6Recruiting: 4Recruiting: 4Terminated: 1Terminated: 1

Departments of GASTROMED Sp. z o.o.


GASTROMED Sp. z o.o. has several departments that took part in Clinical trials: "Gastromed SPK Niepubliczny Zaklad Opieki Zdrowotnej" - 2 trials
Departments List
Total Rows: 1